• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TNF-α 通过 PKR 介导阿尔茨海默病β-淀粉样寡聚体诱导的小鼠和猴子的记忆损伤和脑 IRS-1 抑制。

TNF-α mediates PKR-dependent memory impairment and brain IRS-1 inhibition induced by Alzheimer's β-amyloid oligomers in mice and monkeys.

机构信息

Institute of Medical Biochemistry Leopoldo de Meis, Federal University of Rio de Janeiro, Rio de Janeiro, RJ 21941-902, Brazil.

出版信息

Cell Metab. 2013 Dec 3;18(6):831-43. doi: 10.1016/j.cmet.2013.11.002.

DOI:10.1016/j.cmet.2013.11.002
PMID:24315369
Abstract

Alzheimer's disease (AD) and type 2 diabetes appear to share similar pathogenic mechanisms. dsRNA-dependent protein kinase (PKR) underlies peripheral insulin resistance in metabolic disorders. PKR phosphorylates eukaryotic translation initiation factor 2α (eIF2α-P), and AD brains exhibit elevated phospho-PKR and eIF2α-P levels. Whether and how PKR and eIF2α-P participate in defective brain insulin signaling and cognitive impairment in AD are unknown. We report that β-amyloid oligomers, AD-associated toxins, activate PKR in a tumor necrosis factor α (TNF-α)-dependent manner, resulting in eIF2α-P, neuronal insulin receptor substrate (IRS-1) inhibition, synapse loss, and memory impairment. Brain phospho-PKR and eIF2α-P were elevated in AD animal models, including monkeys given intracerebroventricular oligomer infusions. Oligomers failed to trigger eIF2α-P and cognitive impairment in PKR(-/-) and TNFR1(-/-) mice. Bolstering insulin signaling rescued phospho-PKR and eIF2α-P. Results reveal pathogenic mechanisms shared by AD and diabetes and establish that proinflammatory signaling mediates oligomer-induced IRS-1 inhibition and PKR-dependent synapse and memory loss.

摘要

阿尔茨海默病 (AD) 和 2 型糖尿病似乎具有相似的发病机制。双链 RNA 依赖性蛋白激酶 (PKR) 是代谢紊乱中外周胰岛素抵抗的基础。PKR 磷酸化真核翻译起始因子 2α (eIF2α-P),AD 大脑中表现出升高的磷酸化 PKR 和 eIF2α-P 水平。PKR 和 eIF2α-P 是否以及如何参与 AD 中脑胰岛素信号转导和认知障碍尚不清楚。我们报告说,β-淀粉样寡聚体,AD 相关毒素,以肿瘤坏死因子 α (TNF-α) 依赖的方式激活 PKR,导致 eIF2α-P、神经元胰岛素受体底物 (IRS-1) 抑制、突触丢失和记忆损伤。AD 动物模型中的大脑磷酸化 PKR 和 eIF2α-P 升高,包括给予脑室寡聚体输注的猴子。寡聚体未能在 PKR(-/-)和 TNFR1(-/-)小鼠中引发 eIF2α-P 和认知障碍。增强胰岛素信号转导可挽救磷酸化 PKR 和 eIF2α-P。结果揭示了 AD 和糖尿病共有的发病机制,并确立了促炎信号转导介导了寡聚体诱导的 IRS-1 抑制和 PKR 依赖性突触和记忆丧失。

相似文献

1
TNF-α mediates PKR-dependent memory impairment and brain IRS-1 inhibition induced by Alzheimer's β-amyloid oligomers in mice and monkeys.TNF-α 通过 PKR 介导阿尔茨海默病β-淀粉样寡聚体诱导的小鼠和猴子的记忆损伤和脑 IRS-1 抑制。
Cell Metab. 2013 Dec 3;18(6):831-43. doi: 10.1016/j.cmet.2013.11.002.
2
Proteostasis impairment: at the intersection between Alzheimer's disease and diabetes.蛋白稳态失调:阿尔茨海默病与糖尿病的交汇点。
Cell Metab. 2013 Dec 3;18(6):771-2. doi: 10.1016/j.cmet.2013.11.009.
3
An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease- associated Aβ oligomers.一种抗糖尿病药物可保护小鼠大脑免受与阿尔茨海默病相关的 Aβ寡聚物引起的胰岛素信号缺陷。
J Clin Invest. 2012 Apr;122(4):1339-53. doi: 10.1172/JCI57256.
4
Beta-amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun N-terminal kinase signaling: suppression by omega-3 fatty acids and curcumin.β-淀粉样寡聚体通过c-Jun氨基末端激酶信号通路诱导tau蛋白磷酸化和胰岛素受体底物失活:ω-3脂肪酸和姜黄素的抑制作用
J Neurosci. 2009 Jul 15;29(28):9078-89. doi: 10.1523/JNEUROSCI.1071-09.2009.
5
Oxidative stress increases BACE1 protein levels through activation of the PKR-eIF2α pathway.氧化应激通过激活PKR-eIF2α途径增加β-分泌酶1(BACE1)蛋白水平。
Biochim Biophys Acta. 2012 Jun;1822(6):885-96. doi: 10.1016/j.bbadis.2012.01.009. Epub 2012 Jan 28.
6
Neuronal stress signaling and eIF2α phosphorylation as molecular links between Alzheimer's disease and diabetes.神经元应激信号传导和真核生物翻译起始因子2α(eIF2α)磷酸化作为阿尔茨海默病与糖尿病之间的分子联系。
Prog Neurobiol. 2015 Jun;129:37-57. doi: 10.1016/j.pneurobio.2015.03.003. Epub 2015 Apr 6.
7
PKR knockout in the 5xFAD model of Alzheimer's disease reveals beneficial effects on spatial memory and brain lesions.阿尔茨海默病5xFAD模型中的PKR基因敲除对空间记忆和脑损伤具有有益影响。
Aging Cell. 2019 Jun;18(3):e12887. doi: 10.1111/acel.12887. Epub 2019 Mar 1.
8
A Novel Selective PKR Inhibitor Restores Cognitive Deficits and Neurodegeneration in Alzheimer Disease Experimental Models.一种新型选择性 PKR 抑制剂可恢复阿尔茨海默病实验模型中的认知缺陷和神经退行性变。
J Pharmacol Exp Ther. 2021 Sep;378(3):262-275. doi: 10.1124/jpet.121.000590. Epub 2021 Jun 16.
9
Ablation of TNF-RI/RII expression in Alzheimer's disease mice leads to an unexpected enhancement of pathology: implications for chronic pan-TNF-α suppressive therapeutic strategies in the brain.阿尔茨海默病小鼠 TNF-RI/RII 表达的消融导致病理的意外增强:对大脑中慢性全 TNF-α抑制性治疗策略的影响。
Am J Pathol. 2011 Oct;179(4):2053-70. doi: 10.1016/j.ajpath.2011.07.001. Epub 2011 Aug 9.
10
Upstream signaling pathways leading to the activation of double-stranded RNA-dependent serine/threonine protein kinase in beta-amyloid peptide neurotoxicity.在β-淀粉样肽神经毒性中导致双链RNA依赖性丝氨酸/苏氨酸蛋白激酶激活的上游信号通路。
J Biol Chem. 2003 Dec 12;278(50):49819-27. doi: 10.1074/jbc.M306503200. Epub 2003 Sep 15.

引用本文的文献

1
Incretin Hormones GLP-1 and GIP Normalize Energy Utilization and Reduce Inflammation in the Brain in Alzheimer's Disease and Parkinson's Disease: From Repurposed GLP-1 Receptor Agonists to Novel Dual GLP-1/GIP Receptor Agonists as Potential Disease-Modifying Therapies.肠促胰岛素激素GLP-1和GIP使阿尔茨海默病和帕金森病患者大脑中的能量利用正常化并减轻炎症:从GLP-1受体激动剂的重新利用到新型GLP-1/GIP双受体激动剂作为潜在的疾病修饰疗法。
CNS Drugs. 2025 Sep 12. doi: 10.1007/s40263-025-01226-z.
2
Diabetic retinopathy and Alzheimer's disease: Convergence of the unfolded protein response in neurodegeneration.糖尿病视网膜病变与阿尔茨海默病:神经退行性变中未折叠蛋白反应的交汇
Alzheimers Dement. 2025 Aug;21(8):e70497. doi: 10.1002/alz.70497.
3
Neuroinflammation Based Neurodegenerative In Vitro Model of SH-SY5Y Cells-Differential Effects on Oxidative Stress and Insulin Resistance Relevant to Alzheimer's Pathology.
基于神经炎症的SH-SY5Y细胞神经退行性体外模型——对与阿尔茨海默病病理学相关的氧化应激和胰岛素抵抗的不同影响
Int J Mol Sci. 2025 Jul 9;26(14):6581. doi: 10.3390/ijms26146581.
4
Neural Metabolic Networks: Key Elements of Healthy Brain Function.神经代谢网络:健康脑功能的关键要素
J Neurochem. 2025 Jun;169(6):e70084. doi: 10.1111/jnc.70084.
5
Antidiabetic GLP-1 Receptor Agonists Have Neuroprotective Properties in Experimental Animal Models of Alzheimer's Disease.抗糖尿病胰高血糖素样肽-1受体激动剂在阿尔茨海默病实验动物模型中具有神经保护特性。
Pharmaceuticals (Basel). 2025 Apr 23;18(5):614. doi: 10.3390/ph18050614.
6
Alzheimer's Is a Multiform Disease of Sustained Neuronal Integrated Stress Response Driven by the C99 Fragment Generated Independently of AβPP; Proteolytic Production of Aβ Is Suppressed in AD-Affected Neurons: Evolution of a Theory.阿尔茨海默病是一种由独立于淀粉样前体蛋白(AβPP)产生的C99片段驱动的持续性神经元综合应激反应的多形性疾病;在受阿尔茨海默病影响的神经元中,Aβ的蛋白水解产生受到抑制:一种理论的演变
Int J Mol Sci. 2025 Apr 29;26(9):4252. doi: 10.3390/ijms26094252.
7
Chronic IL-21 drives neuroinflammation and promotes lipid accumulation in microglia.慢性白细胞介素-21驱动神经炎症并促进小胶质细胞中的脂质积累。
Immun Ageing. 2025 Apr 29;22(1):15. doi: 10.1186/s12979-025-00510-2.
8
Integrator loss leads to dsRNA formation that triggers the integrated stress response.整合因子缺失会导致双链RNA形成,从而触发整合应激反应。
Cell. 2025 Jun 12;188(12):3184-3201.e21. doi: 10.1016/j.cell.2025.03.025. Epub 2025 Apr 14.
9
Incretin-based therapeutics for the treatment of neurodegenerative diseases.用于治疗神经退行性疾病的基于肠促胰岛素的疗法。
Nat Metab. 2025 Apr;7(4):679-696. doi: 10.1038/s42255-025-01263-4. Epub 2025 Apr 10.
10
Multi-target approach to Alzheimer's disease prevention and treatment: antioxidant, anti-inflammatory, and amyloid- modulating mechanisms.阿尔茨海默病预防与治疗的多靶点方法:抗氧化、抗炎和淀粉样蛋白调节机制。
Neurogenetics. 2025 Apr 1;26(1):39. doi: 10.1007/s10048-025-00821-y.